Device Trial Radar · NCT01783132
Optimization of Inhaled Corticosteroid Treatment in Adult Patients With Asthma Guided by Exhaled NO Measurement at Home
Last checked: Nov 19, 2026Latest source record: Sep 6, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
142
Actual
Start
Dec 1, 2012
Primary completion
Apr 1, 2014
Study completion Apr 28, 2014
Sponsor
- Lead sponsor
- Orion Corporation, Orion PharmaNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Aerocrine AB
- First posted
- Feb 4, 2013
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To compare the clinical outcome (effectiveness) of single inhaled corticosteroid (ICS) controller treatment guided by exhaled NO measurement made at home with usual care asthma management with regard to asthma control (primary outcome), asthma-related quality of life, lung function, airway inflammation, medication use, and asthma events. To understand changes in patient behaviour triggered by daily FENO measurement at home, for example treatment adherence and voluntary allergen exposure.
Conditions
- Asthma
Interventions
NIOX MINODevice
Active group (Budesonide) will be measuring exhaled NO at least 3 times/week at home to control their Asthma treatment via a algorithm schedule. The control group (Standard of care) will be measuring exhaled NO 4 times/year at study site.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Asthma symptoms in correlation to grade of inflammation in airwaysTime frame: Up to 1 year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Lungkliniken, Universitetssjukhuset i Uppsala
Uppsala, Sweden
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.